US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioinvent International AB

3.29

0.0000

Volume:- -

Turnover:- -

Market Cap:216.40M

PE:-6.92

High:3.29

Open:3.29

Low:3.29

Close:3.29

52wk High:4.70

52wk Low:3.29

Shares:65.80M

Float Shares:32.82M

Volume Ratio:4.99

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4753

EPS(LYR):-0.4994

ROE:-30.60%

ROA:-19.02%

PB:2.52

PE(LYR):-6.59

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Bioinvent International AB

Exchange:

PINK LIMITED

Establishment Date:

1996

Employees:

122

Office Location:

The Gamma Building,Ideongatan 1,Lund,Skåne County,Sweden

Website:

- -

Zip Code:

223 70

Phone:

46 4 62 86 85 50

Fax:

- -

Introduction:

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 for solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a partnership and collaboration with Transgene to co-develop BT-001 multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BT-001 in combination with Keytruda, and in BI-1808. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOVNF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOVNF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOVNF\",,,,,undefined,":{"symbol":"BOVNF","market":"US","secType":"STK","nameCN":"Bioinvent International AB","latestPrice":3.2886,"timestamp":1756843200000,"preClose":3.2886,"halted":0,"volume":0,"delay":15,"floatShares":32815306,"shares":65804362,"eps":-0.475308,"marketStatus":"Pre-Mkt","change":0,"latestTime":"09-02 16:00:00 EDT Delay","open":3.2886,"high":3.2886,"low":3.2886,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.475308,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756906200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.2886,"volumeRatio":4.989178601437883},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOVNF\",,,,,undefined,":{"symbol":"BOVNF","floatShares":32815306,"roa":"-19.02%","roe":"-30.60%","lyrEps":-0.499403,"volumeRatio":4.989178601437883,"shares":65804362,"dividePrice":0,"high":3.2886,"amplitude":0,"preClose":3.2886,"low":3.2886,"week52Low":3.2886,"pbRate":"2.52","psRate":"8.05","week52High":4.7,"institutionHeld":0,"latestPrice":3.2886,"eps":-0.475308,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.475308,"open":3.2886,"prevYearClose":4.7,"prevWeekClose":3.2886,"prevMonthClose":3.2886,"prevQuarterClose":3.2886,"fiveDayClose":3.2886,"twentyDayClose":3.2886,"sixtyDayClose":4.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOVNF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-24","symbol":"BOVNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"","actualEps":null},{"date":"2022-10-27","symbol":"BOVNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666857600000,"name":null,"time":"Pre-Market","dateTimestamp":1666843200000,"actualEps":null},{"date":"2022-08-25","symbol":"BOVNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1661414400000,"name":null,"time":"Pre-Market","dateTimestamp":1661400000000,"actualEps":null},{"date":"2022-04-27","symbol":"BOVNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1651046400000,"name":null,"time":"Pre-Market","dateTimestamp":1651032000000,"actualEps":null},{"market":"US","date":"2020-12-14","symbol":"BOVNF","defaultRemindTime":1607956200000,"type":"split","dateTimestamp":1607922000000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOVNF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BOVNF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1743480000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":139682,"yearFounded":1996,"employeeNum":122,"address":"The Gamma Building,Ideongatan 1,Lund,Skåne County,Sweden","zipCode":"223 70","officePhone":"46 4 62 86 85 50"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.1299},{"period":"1year","weight":-0.5191},{"period":"ytd","weight":-0.5191}],"description":"BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 for solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a partnership and collaboration with Transgene to co-develop BT-001 multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BT-001 in combination with Keytruda, and in BI-1808. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.","exchange":"PINK LIMITED","name":"Bioinvent International AB","nameEN":"Bioinvent International AB"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BOVNF\",market:\"US\",,,undefined,":null}}